Can a simple spit test predict chemo-related deafness in kids?
NCT ID NCT02425397
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at 119 children who had platinum-based chemotherapy for certain cancers. Researchers wanted to find out if certain genes make some kids more likely to develop hearing loss from the treatment. By analyzing DNA from saliva samples, they hope to identify high-risk children early so doctors can adjust treatment or develop preventive measures.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER IN CHILDREN are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Institut Curie
Paris, 75005, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can eye movements reveal the hidden toll of hearing loss?
- A digital helping hand for new hearing aid wearers?
- Could a hearing aid be a shield against dementia?
- Can an online program replace clinic visits for hearing aid users?
- A simple blood test may reveal hidden infertility risk in young cancer survivors
- Can engineered immune cells tackle childhood sarcoma?